查找临床试验
已按「克罗恩病」检索，对应国际通用词 Crohn disease
共找到 72 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 23:03，每 5 分钟自动同步Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease
China
年龄 18 Years – 70 Years
Sixth Affiliated Hospital, Sun Yat-sen University
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
United States、Australia、Austria、Belgium、Brazil 等 12 国
年龄 16 Years – 80 Years
Merck Sharp & Dohme LLC
Real-World Study of IL-23 Inhibitors in Active Crohn's Disease
China
年龄 18 Years – 75 Years
Sixth Affiliated Hospital, Sun Yat-sen University
Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
China
年龄 18 Years – 70 Years
Sixth Affiliated Hospital, Sun Yat-sen University
A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab
China
年龄 18 Years – 75 Years
Second Affiliated Hospital, Zhejiang University, School of Medicine
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
China
年龄 18 Years – 65 Years
Second Affiliated Hospital, Zhejiang University, School of Medicine
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
United States、Austria、Belgium、Canada、China 等 12 国
年龄 18 Years – 不限
Janssen Research & Development, LLC
Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study
China
年龄 18 Years – 80 Years
The Third Xiangya Hospital of Central South University
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
United States、Australia、Austria、Bosnia and Herzegovina、Brazil 等 12 国
年龄 18 Years – 85 Years
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Epidemiological Characteristics and Efficacy Evaluation of Difficult-To-Treat Crohn's Disease
China
年龄 18 Years – 65 Years
Xiang Gao
Specific Dietary Pattern for Crohn's Disease Patients Following Surgery
China
年龄 14 Years – 不限
Second Affiliated Hospital, Zhejiang University, School of Medicine
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
China
年龄 3 Years – 不限
Chen QiYi